Patents Assigned to Anapole Technologies, Inc.
  • Patent number: 11147467
    Abstract: An electromagnetic resonance-based disease detecting system may comprising a spectrum analyzer assembly comprised of one of a spectrum analyzer with an internal tracking generator or a spectrum analyzer with a separate signal generator, a radiating antenna electronically connected to the spectrum analyzer assembly output and configured to radiate a subject with an electromagnetic field based on a resonant frequency signal, wherein radiating a subject with the electromagnetic field generates a subject spectrum; a receiving antenna configured to receive the subject spectrum; a spectrum analyzer electronically connected to the receiving antenna and configured to receive the subject spectrum from the receiving antenna; and a processor, the processor being operatively connected to the spectrum analyzer assembly, the radiating antenna, the receiving antenna, and the spectrum analyzer, wherein the processor is configurable to store and control the resonant frequency signal generated by the spectrum analyzer assembly
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: October 19, 2021
    Assignee: ANAPOLE TECHNOLOGIES INC.
    Inventors: Stephen F. Botsford, Vitaly M. Seltser, Joseph F. Startari
  • Patent number: 10279190
    Abstract: The present disclosure relates, according to some embodiments, to an electromagnetic resonance-based disease treatment system that comprises a processing unit configured to generate a resonant frequency signal and a radiating antenna configured to radiate an electromagnetic field based on the resonant frequency signal. The resonant frequency signal may carry at least one frequency at which reference materials related to a disease condition resonate. An antenna configuration may be used to determine one or more resonant frequencies of the reference materials. A subject having or at risk of having the disease condition may be exposed to the electromagnetic field in order to treat the disease condition.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: May 7, 2019
    Assignee: Anapole Technologies Inc.
    Inventors: Stephen F. Botsford, Boris I. Kokorin, Joseph F. Startari
  • Patent number: 9610458
    Abstract: The present disclosure relates, according to some embodiments, to an electromagnetic resonance-based disease treatment system that comprises a processing unit configured to generate a resonant frequency signal and a radiating antenna configured to radiate an electromagnetic field based on the resonant frequency signal. The resonant frequency signal may carry at least one frequency at which reference materials related to a disease condition resonate. An antenna configuration may be used to determine one or more resonant frequencies of the reference materials. A subject having or at risk of having the disease condition may be exposed to the electromagnetic field in order to treat the disease condition.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: April 4, 2017
    Assignee: Anapole Technologies, Inc.
    Inventors: Stephen F. Botsford, Boris I. Kokorin, Joseph F. Startari